Surgical therapy for Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Journal of Neurology

• Publication date

  2002-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1468-1331.9.S3.4.XPMID 12464119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of thalamotomy in the treatment of levodopa-induced dyskinesia

  2005cited by this paper
• Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues

  2004cited by this paper
• Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

  2002cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Early morning off-medication dyskinesias, dystonia, and choreic subtypes.

  2001cited by this paper
• DBS and diathermy interaction induces severe CNS damage

  2001cited by this paper
• Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

  2001cited by this paper
• Dorsal subthalamotomy for Parkinson's disease

  2001cited by this paper
• An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.

  2001cited by this paper
• Surgical therapies for Parkinson's disease. A physician's perspective.

  2001cited by this paper
• Mechanism of action of deep brain stimulation.

  2000cited by this paper
• A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.

  2000cited by this paper
• Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease.

  2000cited by this paper
• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  2000cited by this paper
• Pathophysiology of the basal ganglia in Parkinson's disease.

  2000cited by this paper
• Transient acute depression induced by high-frequency deep-brain stimulation.

  1999cited by this paper
• Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.

  1999cited by this paper
• Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.

  1999cited by this paper
• New prospects for human stem-cell therapy in the nervous system.

  1999cited by this paper
• Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.

  1999cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

  1998cited by this paper
• Neuropathology of fetal nigral grafts in patients with Parkinson's disease.

  1998cited by this paper
• Bilateral high‐frequency stimulation of the internal globus pallidus in advanced Parkinson's disease

  1998cited by this paper
• An algorithm (decision tree) for the management of Parkinson’s disease (2001):

  1998cited by this paper
• Deep brain stimulation in Parkinson's disease: Opposite effects of stimulation in the pallidum

  1998cited by this paper
• Subthalamic nucleus‐mediated excitotoxicity in parkinson's disease: A target for neuroprotection

  1998cited by this paper
• Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  1998cited by this paper
• Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease

  1998cited by this paper
• High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease

  1997cited by this paper
• Pallidal stimulation for Parkinson's disease

  1997cited by this paper
• Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease

  1997cited by this paper
• Posteroventral medial pallidotomy in advanced Parkinson's disease.

  1997cited by this paper
• High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor

  1997cited by this paper
• Posteroventral medial pallidotomy in advanced Parkinson's disease.

  1997cited by this paper
• Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants.

  1997cited by this paper
• Immortalized neural progenitor cells for CNS gene transfer and repair.

  1997cited by this paper
• Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

  1997cited by this paper
• Postembryonic changes in the structure of the olfactory bulb of the chinook salmon (Oncorhynchus tshawytscha) across its life history.

  1997cited by this paper
• Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies

  1996cited by this paper
• Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1‐year results of a pilot study

  1996cited by this paper
• Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical Studies

  1996cited by this paper
• Fetal nigral transplantation as a therapy for Parkinson's disease.

  1996cited by this paper
• Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.

  1996cited by this paper
• Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders.

  1996cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• GPi pallidotomy—have we made a dent in Parkinson's disease?

  1996cited by this paper
• Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

  1995cited by this paper
• Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease

  1995cited by this paper
• Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.

  1995cited by this paper
• Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor.

  1995cited by this paper
• Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys

  1995cited by this paper
• Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patients

  1995cited by this paper
• Stereotactic ventral pallidotomy for Parkinson's disease

  1995cited by this paper
• Bilateral subthalamic nucleus stimulation for severe Parkinson's disease

  1995cited by this paper
• Long‐term thalamic stimulation in Parkinson's disease

  1994cited by this paper
• The Metabolic Topography of Parkinsonism

  1994cited by this paper
• The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.

  1994cited by this paper
• Neurotrophic factors: from molecule to man.

  1994cited by this paper
• Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms.

  1994cited by this paper
• Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon.

  1994cited by this paper
• Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated Monkeys

  1993cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• Transplantation of fetal dopamine neurons in Parkinson's disease: PET {18F}6‐L‐fluorodopa studies in two patients with putaminal implants

  1992cited by this paper
• Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding.

  1992cited by this paper
• Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

  1992cited by this paper
• Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.

  1992cited by this paper
• Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implants

  1992cited by this paper
• Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate.

  1992cited by this paper
• Posteroventral pallidotomy for Parkinson's disease.

  1992cited by this paper
• Contralateral disappearance of parkinsonian signs after subthalamic hematoma

  1992cited by this paper
• Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus.

  1992cited by this paper
• Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms.

  1992cited by this paper
• Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.

  1992cited by this paper
• Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus.

  1991cited by this paper
• Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients.

  1991cited by this paper
• Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

  1991cited by this paper
• Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.

  1990cited by this paper
• Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results.

  1990cited by this paper
• Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

  1990cited by this paper
• Primate models of movement disorders of basal ganglia origin.

  1990cited by this paper
• The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies.

  1990cited by this paper
• Stereotaxic Vim thalamotomy for treatment of tremor.

  1989cited by this paper
• Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.

  1989cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

  1988cited by this paper
• Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

  1987cited by this paper
• Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen

  1987cited by this paper
• Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease.

  1987cited by this paper
• Long-term follow-up study of nucleus ventralis intermedius and ventrolateralis thalamotomy using a microelectrode technique in parkinsonism.

  1987cited by this paper
• Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine.

  1986cited by this paper
• Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey.

  1985cited by this paper
• Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy.

  1984cited by this paper
• Levodopa-induced dyskinesia and thalamotomy.

  1984cited by this paper
• What happened to VIM thalamotomy for Parkinson's disease?

  1983cited by this paper
• The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study.

  1980cited by this paper
• Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.

  1979cited by this paper
• Physiological study of presumed ventralis intermedius neurons in the human thalamus.

  1979cited by this paper
• Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system.

  1979cited by this paper
• Surgical aspects.

  1967cited by this paper

• Effects of Exercise on Balance, Gait Speed, Quality of Life, and Symptom Relief Among Older Adults with Parkinson’s Disease: A Meta-Analysis of Randomized Controlled Trials (RCTs)

  2025cites this paper
• Stem Cell Therapy in Parkinson’s Disease: Advances in Regenerative Medicine and Clinical Applications

  2025cites this paper
• The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson’s disease

  2022cites this paper
• GOCOVRI® (amantadine) extended-release capsules in Parkinson's disease.

  2021cites this paper
• Cortical neuroprosthetics from a clinical perspective.

  2015cites this paper
• Ultrasound-triggered and targeted gene delivery by using cationic microbubbles to enhance GDNF gene transfection in a rat Parkinson's disease model

  2015cites this paper
• and targeted gene delivery by using cationic microbubbles to enhance GDNF gene transfection in a rat Parkinson's disease model

  2015cites this paper
• International Journal for Pharmaceutical Research Scholars (IJPRS)

  2014cites this paper
• Alternative therapies for Morbus Parkinson: Effects of tactile stimulation in a rodent model of Parkinsons disease and induced pluripotent stem cells as a new source for neurotransplantation - therapy

  2014cites this paper
• Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions.

  2011cites this paper
• Delivery of chemotropic proteins and improvement of dopaminergic neuron outgrowth through a thixotropic hybrid nano-gel

  2011cites this paper
• Surgical approaches to treatment of Parkinson's disease: Implications for speech function

  2010cites this paper
• Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.

  2009cites this paper
• Tissue Transplantation for Parkinson’s Disease

  2009cites this paper
• Survival and functional recovery of transplanted human dopaminergic neurons into hemiparkinsonian rats depend on the cannula size of the implantation instrument.

  2008cites this paper
• High-Frequency Stimulation of the Subthalamic Nucleus Potentiates l-DOPA-Induced Neurochemical Changes in the Striatum in a Rat Model of Parkinson's Disease

  2007cites this paper
• [Dyskinesia in Parkinson's disease--major clinical features, aetiology, therapy].

  2007cites this paper
• Advances in the treatment of Parkinson's disease.

  2007cites this paper
• Neuroprotective effects of metabotropic glutamate receptor ligands in a 6‐hydroxydopamine rodent model of Parkinson's disease

  2005cites this paper
• High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.

  2005cites this paper
• FDG PET in the differential diagnosis of parkinsonian disorders

  2005cites this paper
• Neurodegenerative Diseases: Necessary methodological and stem cell advances for restoration of the dopaminergic system in Parkinson's disease patients

  2005cites this paper
• SHORT COMMUNICATION Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease

  2005cites this paper
• Surgical Treatment of Tremo

  2005cites this paper
• Diagnostic staging of Parkinson’s disease: conceptual aspects

  2004cites this paper
• Future therapies for Parkinson's disease.

  2004cites this paper
• Deep brain stimulation of the subthalamic nucleus in Parkinson's Disease 1993 – 2003: where are we 10 years on?

  2004cites this paper
• Disease-modifying strategies and challenges in PD

  2003cites this paper
• The role of the thalamus in motor control.

  2003cites this paper
• Making and repairing the mammalian brain--in vitro production of dopaminergic neurons.

  2003cites this paper